NCT00477048View on ClinicalTrials.gov

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
IDV Associated Nephrotoxicity
Interventions
DRUG

Saquinavir

SQV/r 1000/100 BID + NNRTI or SQV/r 1600/100 OD + 2 NRTI

Trial Locations (1)

10330

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Ministry of Health, Thailand

OTHER_GOV

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

NCT00477048 - Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity | Biotech Hunter | Biotech Hunter